However, any reputable pharmacy will assign BUDs based on testing or validated guidelines for their specific concentration
Want to improve overall wellness and vitality
Additionally, research published in Drug Testing and Analysis characterizing AOD9604 metabolism and confirming its C-terminal HGH fragment structure, supporting its classification as a non-IGF-1-stimulating lipolytic agent has been used by clinicians evaluating the compound for metabolic applications
Possible Side Effects While most users tolerate AOD9604 well, mild side effects can occur: Injection site reactions Redness, itching, or mild swelling may appear, especially if rotation of injection sites is inconsistent
Control mice, by comparison, gained 1.4% over the same period
While the peptide does not increase IGF-1, caution is warranted given the theoretical relationship between growth factors and cancer progression